+++
title = "Accelerate Virtual Screening with Amortized Neural Search and Multi-Objective Bayesian Optimization"
date = "2024-11-09"
outputs = ["Reveal"]
math=true
codeFences = true

+++

{{< slide auto-animate="" >}}
### Accelerate Virtual Screening 
### with Amortized Neural Search 
### and Prefential Bayesian Optimization

<div style="display: flex; justify-content: space-between; width: 100%;">
  <img src="images/SOM_vert_Web_Color_LG.png" alt="Main Logo" style="height: 70px; margin-left: -150px;"> 
  <img src="images/sail-logo.jpg" alt="Second Logo" style="height: 70px; margin-right: -180px;">
</div>

---
{{< slide auto-animate="" >}}
### 1.Introduction: Virtual Screening

For **a given protein** linked to a certain disease,
{{% fragment %}}the goal of virtual screening is to select a **few** small molecules (i.e., ligand){{% /fragment %}}
{{% fragment %}}from a library of **millions** candidates{{% /fragment %}}
{{% fragment %}}such that the selected candidate will have the **highest utility** in disease treating.{{% /fragment %}}

<span class="fragment">
    <figure style="display: flex; flex-direction: column; align-items: center; width: 80%; margin-top: 0px; margin-left: 100px">
    <img src="images/vs.png">
</span>

---
{{< slide auto-animate="" >}}
### 1.Introduction: Virtual Screening

<span class="fragment">For modern libraries, it is feasible scaling up to billions or even trillions of compounds enhances the reach and impact of virtual screening.</span>

<span class="fragment">
    <figure style="display: flex; flex-direction: column; align-items: center; width: 80%; margin-top: 0px; margin-left: 100px">
    <img src="images/vs.png">
</span>

---
{{< slide auto-animate="" >}}
### 1.Introduction: Virtual Screening

<div style="display: flex; justify-content: space-between; align-items: flex-start;">
  <div style="width: 50%;">
    <h3 style="font-size: 28px; margin-bottom: 10px;">Virtual screening presents several challenges:</h3>
    <ol style="font-size: 24px; padding-left: 20px;">
      <li class="fragment" data-fragment-index="1"><strong>Multiple, competing objectives</strong> based on unknown, hard-to-quantify expert knowledge.</li>
      <li class="fragment" data-fragment-index="2"><strong>Limited budget</strong> to try all ligands from the library.</li>
      <li class="fragment" data-fragment-index="3">Some objectives (such as binding affinity) are expensive to evaluate even for a single ligand.</li>
    </ol>
  </div>

  <div style="width: 50%;">
    <h3 style="font-size: 28px; margin-bottom: 10px;">Our research aims to address these challenges:</h3>
    <ol style="font-size: 24px; padding-left: 20px;">
      <li class="fragment" data-fragment-index="1">Actively eliciting expert preferences for virtual screening with many objectives.</li>
      <li class="fragment" data-fragment-index="2">Active Virtual Screening.</li>
      <li class="fragment" data-fragment-index="3">Neural Search Engine with diffusion model.</li>
    </ol>
  </div>
</div>


---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition
Depending on the specific disease and protein, experts have **intuition** about characteristics of candidate ligands,
{{% fragment %}}trading off various objectives such as synthesizability, affinity, solubility, and side effects.{{% /fragment %}}

<span class="fragment">
  <div style="display: flex; justify-content: center; width: 100%; gap: -30px; margin-top: -100px;">
    <figure style="display: flex; flex-direction: column; align-items: center; width: 45%;">
      <img src="images/lig1.png" style="width: 100%;" alt="Aff: -10.11, PSA: 67.66">
      <figcaption style="text-align: left; font-size: 20px; margin-top: -50px;">Affinity: -10.11, Solubility: 67.66</figcaption>
    </figure>
    <figure style="display: flex; flex-direction: column; align-items: center; width: 45%;">
      <img src="images/lig2.png" style="width: 100%;" alt="Aff: -10.11, PSA: 67.66">
      <figcaption style="text-align: left; font-size: 20px; margin-top: -50px;">Affinity: -10.11, Solubility: 67.66</figcaption>
    </figure>
  </div>
</span>


---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition
These implicit expert knowledge, encoded as preferences over ligands, are valuable to elicit for effective virtual screening.
{{% fragment %}}We can leverage toolkits from the field of machine learning from human preferences to tackle this challenge.{{% /fragment %}}

<span class="fragment">
<table style="width: 80%; margin-top: 20px; border-collapse: collapse; text-align: center; font-size: 18px;">
  <tr>
    <th style="border: 1px solid #ddd; padding: 8px;">First ligand</th>
    <th style="border: 1px solid #ddd; padding: 8px;">Second ligand</th>
    <th style="border: 1px solid #ddd; padding: 8px;">Preference $(x_1 \succ x_2)$</th>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-7.81, 114.38, 0.51]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">0</td>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-10.45, 186.17, 0.29]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">1</td>
  </tr>
  <tr>
    <td style="border: 1px solid #ddd; padding: 8px;">[-6.18, 35.32, 0.83]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">[-8.12, 116.28, 0.47]</td>
    <td style="border: 1px solid #ddd; padding: 8px;">0</td>
  </tr>
</table>

<p style="font-size: 20px; text-align: center; margin-top: 15px;">
  <em>Each ligand is represented by a set of features, such as affinity, polar surface area, QED drug-likeness score</em>
</p>
</span>

---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition

Learning a preference model from binary preference data can be viewed as learning a classifier. 

  {{% fragment %}}
  ```math
  p(y \mid x_1, x_2; f) = \frac{e^{f(x_1)}}{e^{f(x_1)} + e^{f(x_2)}}
  ```
  {{% /fragment %}}

  {{% fragment %}}
  ```math
  = \frac{1}{1 + e^{-[f(x_1)-f(x_2)]}}
  ```
  {{% /fragment %}}

  {{% fragment %}}
  ```math
  = \sigma(f(x_1)-f(x_2))
  ```
  {{% /fragment %}}

{{% fragment %}}where $\sigma(\cdot)$ is the sigmoid function.{{% /fragment %}}

---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition
{{% fragment %}}The latent utility function $f$ can be modeled using various approaches.{{% /fragment %}}
{{% fragment %}} One popular choice is the **Gaussian Process (GP)**, a non-parametric Bayesian method that defines a distribution over possible functions.{{% /fragment %}}

<p style="color: green;">Add a visualization for functions induced by different kernel here.</p>


---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition

{{% fragment %}}By modeling utility with a Gaussian Process, we effectively capture both the uncertainty and the non-linear relationships inherent in expert preferences.{{% /fragment %}}
{{% fragment %}}Learning GP Classifier can be done with standard machine learning toolbox such as `scikit-learn`.{{% /fragment %}}

{{% fragment %}}For example, when the synthetic oracle is the Auckley function, we obtain 95% train and test accuracy.{{% /fragment %}}

---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition

Learning chemical intuition is done in a close-loop, where the computer interacts with the chemist in an active manner.
{{% fragment %}}Starting with distribution over function $f$ condition on the current data, $p(f | D)$, our procedure includes 4 iterative steps:{{% /fragment %}}

{{% fragment %}}**Step 1:** Sample two candidate utility: $f_1 \sim p(f|D), f_2 \sim p(f|D)$ {{% /fragment %}}


{{% fragment %}}**Step 2:** Find the best ligand under each utility function:

```math
x_1 = \arg\max_{x \in \mathcal{L}} f_1(x), x_2 = \arg\max_{x \in \mathcal{L}} f_2 (x)$ 
```
{{% /fragment %}}

---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition

**Step 3:** Present the two candidate ligands $x_1$ and $x_2$ to the expert to obtain preference $y$.

{{% fragment %}} **Step 4:** Update the model in the present of new data $\mathcal{D} \leftarrow \mathcal{D} \cup \{(x_1, x_2, y)\}$.
{{% /fragment %}}

<p style="color: green;">Add a graph showing our active elicitation method can quickly find the best candidate $x$ with a minimal amount of query.
Add experiment showing that our method is robust with complex nonlinear function in high dimensional input.</p>


<!-- 
<ul>
  <li class="fragment"><strong>Initial Selection</strong>: Randomly select pairs of ligands from a library \( L \) of 7,000 compounds to explore the chemical space.</li>
  <li class="fragment"><strong>Adaptive Selection</strong>: Optimize future selections from \( L \) to reduce oracle queries, improving efficiency and modeling the latent function \( f \).</li>
  <li class="fragment"><strong>Reward Function</strong>: For utility \( U \) using Gaussian Process Classification \( U = f(\mathbf{X}) \), where:
    <ul style="font-size: 22px;"$>
      <li class="fragment">\( U \): utility score indicating ligand suitability</li>
      <li class="fragment">\( f \): latent function representing expert preferences</li>
      <li class="fragment">\( \mathbf{X} \): ligand feature difference vector \( \mathbf{f}(x_1) - \mathbf{f}(x_2) \)</li>
    </ul>
  </li>
</ul> -->

---
{{< slide auto-animate="" >}}
### 2.Eliciting Chemical Intuition
We have demonstrated that our method can robustly identify candidate ligands that match a complex, latent utility function in a high-dimensional space with a minimal number of queries.

{{% fragment %}}For the next step, we aim to collaborate with experts in the lab to understand their latent utility preferences via pairwise preference elicitation for virtual screening applications.{{% /fragment %}}


  <!-- <p style="font-size: 24px; text-align: left;">For the next step, working with Chemists to encode expert preference as the objective function for virtual screening.</p>
  <ul>
    <li class="fragment">Provide a dataset of ligands characterized by properties such as solubility, toxicity, affinity, requesting chemists to choose their preferences.</li>
    <li class="fragment">Use a classification model to determine the optimal weights (W) that reflect chemist preferences.</li>
    <li class="fragment">Perform active virtual screening to iteratively refine the selection of compounds.</li>
  </ul> -->


---
{{< slide auto-animate="" >}}
## 3. Active Virtual Screening
  <p style="font-size: 24px; text-align: left;">Even with the right trade-off objective elicited from expert, exhaustively screening millions of candidate from the virtual screening library is practically infeasible.</p>
  <p style="font-size: 24px; text-align: left;">To address this problem, we can choose to screen ligand that looks promising, while avoid ligand that are highly certain to be a bad candidate.</p>
  <ul>
    <li class="fragment">Bayesian Optimization: Efficiently explores high-potential ligands.</li>
    <li class="fragment">Surrogate model (selection model): Gaussian Process, Neural net, Random forest</li>
    <li class="fragment">Acquisition function: UCB, Greedy, Thompson sampling</li>
  </ul>
  <img src="images/avs.png" alt="Active Virtual Screening Diagram" style="width: 80%;" class="fragment">

---
{{< slide auto-animate="" >}}
### 4. Neural Diffusion Search
<div style="text-align: left; font-size: 28px; margin-left: 30px;">
  <span class="fragment">
  <p>Traditional physics-based docking tools (e.g., Glide, Smina) are computationally expensive to evaluate ligand affinity.</p>
  </span>
  <ul style="margin-left: 40px;">
    <li class="fragment"> <strong>Traditional Tools</strong>: 15mins/1 pose</li>
    <li class="fragment"> <strong>Our model</strong>: 5s/64 poses</li>
    <li class="fragment"> <strong>Chai</strong>: 1 min/5 poses</li>
  </ul>
</div>

<div style="text-align: left; font-size: 28px; margin-left: 30px;">
  <span class="fragment">
  <p>We leverage the similarity in ligand structure to accelerate the binding by training a diffusion model for molecular docking</p>
  </span>
  <ul style="margin-left: 40px;">
    <li class="fragment"> <strong>Neural Engine</strong>: Uses diffusion model for rapid docking</li>
    <li class="fragment"> <strong>Utility Scoring</strong>: Assesses ligands on affinity, solubility, and toxicity, etc</li>
  </ul>
</div>

---
{{< slide auto-animate="" >}}
### 4. Neural Diffusion Search
<div style="text-align: left; font-size: 28px; margin-left: 30px;">
  <span class="fragment">
  <p>Accelerate pose search further:</p>
  </span>
  <ul style="font-size: 24px; margin-left: 40px;">
    <li class="fragment"> Local vs blind docking</li>
    <li class="fragment"> Blind docking first during initialization, local docking during active screening process</li>
    <li class="fragment"> Obtain centroid positions through ligand initializations for faster docking time</li>
  </ul>
</div>

<span class="fragment">
  <figure style="display: flex; flex-direction: column; align-items: center;">
    <div style="display: flex; justify-content: center; width: 100%;">
        <img src="images/blind_docking.gif" style="width: 60%; margin-right: 10px;" alt="Blind Docking">
        <img src="images/local_docking.gif" style="width: 60%;" alt="Local Docking">
    </div>
    <figcaption style="text-align: center; font-size: 20px; margin-top: 10px;">Blind Docking (left) vs. Local Docking (right)</figcaption>
  </figure>
</span>


---
{{< slide auto-animate="" >}}
### 4. Neural Diffusion Search
<div style="margin-left: 30px;"> 
    <span class="fragment"> 
        <p><strong>Data Augmentation Techniques:</strong></p> 
        <ul style="margin-left: 40px; font-size: 20px"> 
            <li class="fragment"><strong>Molecular Dynamics (MD) Augmentation:</strong> Employed 59,330 dynamic frames of 14,387 protein-ligand complexes to model ligand flexibility, amounting to 75K training data.</li> 
            <li class="fragment"><strong>Data Crawling:</strong> Curated 322K protein-ligand complexes from the PDBScan22 dataset, after filtering out unnatural ligands and problematic poses, to enhance structural diversity.</li> 
            <li class="fragment"><strong>Pharmacophore Alignment:</strong> Generated up to 11M pharmacophore-consistent ligand pairs from the Papyrus dataset, significantly expanding the model's training data.</li> 
        </ul> 
    </span> 
    <span class="fragment">
        <div style="display: flex; justify-content: space-between; margin-top: 20px;">
            <div style="width: 49%;">
                <img src="images/md.gif" alt="MD Simulation Example" style="width: 50%; height: auto; margin-left: 100px;">
                <p style="text-align: center; font-size: 20px; margin-left: 00px; margin-top: -40px;">Figure 1: MD Simulation Trajectories</p>
            </div>
            <div style="width: 49%;">
                <img src="images/pharmacophore.png" alt="Pharmacophore Model Example" style="width: 80%; height: auto;">
                <p style="text-align: center; font-size: 20px">Figure 2: Pharmacophore Modeling</p>
            </div>
        </div>
    </span>
</div>



---
{{< slide auto-animate="" >}}
### 4. Neural Diffusion Search
<div style="margin-left: 30px;"> 
    <span class="fragment"> <p>Diffusion models are probabilistic generative models that transform data from a noisy distribution into a structured, meaningful output through a reverse process.</p> </span> 
    <span class="fragment"> <p>Applying SDEs for controlled generative modeling:</p> </span> 
    <ul style="margin-left: 40px;"> 
        <li class="fragment"> Initiate with Gaussian noise on ligand coordinates</li> 
        <li class="fragment"> Employ Euler-Maruyama to denoise step-by-step: <ul> 
        <li style="font-size: 20px;">$X_{t-\Delta t} = X_t + f(X_t, t) \Delta t + g(t) \sqrt{\Delta t} \cdot \epsilon$</li>
    <li class="fragment"> Optimize ligand structure discovery through iterative sampling steps via Euler</li> 
    </ul> 
</div>

---
{{< slide auto-animate="" >}}
### 4. Neural Diffusion Search
<div style="text-align: left; font-size: 24px; margin-left: 30px;"> <span class="fragment"> <p><strong>Benchmark on Posebusters Dataset:</strong></p> </span> <p class="fragment">Posebusters Version 1 includes 428 protein-ligand structures, and Version 2 has 308, all released to the PDB after 2021. Performance is measured by the percentage of protein-ligand pairs with pocket-aligned ligand RMSD under 2 Ã….</p> </div>

<span class="fragment">
  <figure style="display: flex; flex-direction: column; align-items: center;">
    <div style="display: flex; justify-content: center; width: 100%; gap: 10px; margin-top: -20px;">
        <img src="images/docking_results.png" style="width: 100%; max-width: 1000px;">
    </div>
  </figure>
</span>

---
{{< slide auto-animate="" >}}
## 6. Contrained settings

<div style="text-align: left; font-size: 24px; margin-left: 10px;">
  <span class="fragment">
  <p>This graph showcases the outcome of a PCA-based virtual screening process to identify and compare ligands based on their chemical similarity.</p>
  </span>
  <ul style="text-align: left; font-size: 20px; margin-left: 40px;">
    <li class="fragment">PC1 and PC2: represent the principal components derived from PCA, summarizing complex ligand properties into a comprehensible two-dimensional space.</li>
    <li class="fragment">Similarity Metric: using the Tanimoto coefficient, comparing chemical fingerprints.</li>
  </ul>
</div>

<span class="fragment">
  <figure style="display: flex; flex-direction: column; align-items: center;">
    <div style="display: flex; justify-content: center; width: 95%;">
        <img src="images/similarity.png" style="width: 50%;" alt="Virtual Screening with Multiple Query Ligands and Constrained Similarity">
    </div>
    <figcaption style="text-align: center; font-size: 20px; margin-top: 10px;">Virtual Screening with Multiple Query Ligands and Constrained Similarity</figcaption>
  </figure>
</span>


---
{{< slide auto-animate="" >}}
## 7. Putting it all together
<div style="text-align: left; font-size: 24px; margin-left: 0px;">
  <p>
    <span class="fragment"> We perform active virtual screening on the inferred expert utility function.</span>
    <span class="fragment"> Our procedure respects expert preference (both hard and soft constraint) and probabilistic model to come up with a good candidate set.</span>
    <span class="fragment"> To search for poses required for objectives such as affinity, we accelerate the pose search by a neural search engine.</span>
  </p>
</div>

<div style="text-align: left; font-size: 24px; margin-top: 20px;">
  <span class="fragment"><strong>Metrics for evaluation</strong></span>
</div>

<div style="text-align: left; font-size: 24px; margin-left: 10px;">
  <span class="fragment">
  <p><strong>Regret</strong></p>
  </span>
  <ul style="margin-left: 40px;">
    <li class="fragment"><strong>Definition</strong>: Difference in affinity between the best possible ligand and the top ligand found by the model within the top_k \%\.</li>
    <li class="fragment">\[ \text{Regret} = A_{\text{best}} - A_{\text{model}} \]</li>
  </ul>
</div>

<div style="text-align: left; font-size: 24px; margin-left: 10px;">
  <span class="fragment">
  <p><strong>Percent of Best Ligand Found</strong></p>
  </span>
  <ul style="margin-left: 40px;">
    <li class="fragment"><strong>Definition</strong>: Percentage of screened ligands close in affinity to the best possible ligand. (top_k \%\)</li>
  </ul>
</div>

---
{{< slide auto-animate="" >}}
## 7. Putting it all together: Screening Results
<span class="fragment">
  <figure style="display: flex; flex-direction: column; align-items: center;">
    <div style="display: flex; justify-content: center; width: 100%; gap: 70px; margin-top: -30px;">
        <img src="images/percent.png" style="width: 40%; max-width: 450px;">
        <img src="images/regret.png" style="width: 40%; max-width: 450px;">
    </div>
  </figure>
</span>


---
{{< slide auto-animate="" >}}
## 7. Putting it all together: Screening Results
<span class="fragment">
  <figure style="display: flex; flex-direction: column; align-items: center;">
    <div style="display: flex; justify-content: center; width: 100%; gap: 10px; margin-top: -20px;">
        <img src="images/time.png" style="width: 70%; max-width: 650px;">
    </div>
  </figure>
</span>

---
{{< slide auto-animate="" >}}
## 7. Putting it all together: Next steps
  <ul style="margin-left: 40px;">
    <li class="fragment"> Run virtual screening on bigger library (100k, 1M) compounds</li>
    <li class="fragment"> Improve on performance of diffusion model</li>
  </ul>